{"id":"NCT00855582","sponsor":"Eli Lilly and Company","briefTitle":"A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multinational Study to Evaluate the Efficacy and Safety of Tadalafil 2.5 and 5 mg Once Daily Dosing for 12 Weeks for the Treatment of Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia in Men With Both Erectile Dysfunction and Benign Prostatic Hyperplasia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-03","primaryCompletion":"2010-07","completion":"2010-07","firstPosted":"2009-03-04","resultsPosted":"2011-06-30","lastUpdate":"2011-07-28"},"enrollment":606,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Erectile Dysfunction","Benign Prostatic Hyperplasia"],"interventions":[{"type":"DRUG","name":"Tadalafil","otherNames":["Cialis","LY450190"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Tadalafil 2.5 mg","type":"EXPERIMENTAL"},{"label":"Tadalafil 5 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Study LVHR is a Phase 3 study which will examine the efficacy and safety of tadalafil 2.5 and 5 mg once daily versus placebo for the treatment of erectile dysfunction (ED) and signs and symptoms of benign prostatic hyperplasia (BPH) in men with both ED and signs and symptoms of BPH.","primaryOutcome":{"measure":"Change From Baseline in Total International Prostate Symptom Score (IPSS) at Week 12 Endpoint (5 mg)","timeFrame":"Baseline, 12 weeks","effectByArm":[{"arm":"Tadalafil 5 mg","deltaMin":-6.1,"sd":0.43},{"arm":"Placebo","deltaMin":-3.8,"sd":0.45}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"45 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":19},"locations":{"siteCount":52,"countries":["United States","Canada","France","Germany","Greece","Italy","Mexico","Portugal","Russia"]},"refs":{"pmids":["26299520","24119319"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":198},"commonTop":["Headache","Nasopharyngitis","Influenza","Back pain","Dizziness"]}}